Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;24(1):42-8.
doi: 10.1007/s12291-009-0007-0. Epub 2009 May 8.

Multiple matrix metalloproteinases in type II collagen induced arthritis

Affiliations

Multiple matrix metalloproteinases in type II collagen induced arthritis

S Sandya et al. Indian J Clin Biochem. 2009 Jan.

Abstract

To study the relative contribution of various matrix degrading enzymes in the pathogenesis of arthritis, changes in the levels of various matrix metalloprtoteinases (MMPs) during the progression of collagen induced arthritis was studied in experimental animals. Arthritis was induced in male wistar rats by injecting an emulsion containing collagen type II and Freund's complete adjuvant. The duration of the experiment was 35 days. Synovial effusate was collected at regular intervals after induction. At the end of the experiment serum and cartilage were collected and analysed. Synovial fluid of osteoarthritic patients was also analyzed. Levels of MMP-2, MMP-3, MMP-9 and MT1-MMP were found to be high in synovial effusate and cartilage of experimental animals. In synovial effusate of arthritic animals the expression of MMP-3 was found to be high during the early stages while increase in MMP-2 and MMP-9 occurred at later stages. Synovial fluid of osteoarthritic patients also showed elevated levels of MMP-2, MMP-3 and MMP-9. Our results indicated that sequential action of MMPs such as MMP-3, MMP-2 and MMP-9 can cause degradation of articular cartilage extracellular matrix.

Keywords: Matrix metalloproteinases; Osteoarthritis; Synovial effusate; Synovial fluid.

PubMed Disclaimer

References

    1. Lotz M., Hashimoto S., Kuhn K. Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage. 1999;7:389–391. doi: 10.1053/joca.1998.0220. - DOI - PubMed
    1. Buttle D.J., Bramwell H., Hollander A.P. Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy? Clin Pathol Mol Pathol. 1995;48:167–177. doi: 10.1136/mp.48.4.M167. - DOI - PMC - PubMed
    1. Murphy G., Reynolds J.J. Current views of collagen degradation. Progress towards understanding the resorption of connective tissues. Bio Essays. 1985;2:55–60.
    1. Kozaci L.D., Buttle D.J., Hollander A.P. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum. 1997;40:164–174. doi: 10.1002/art.1780400121. - DOI - PubMed
    1. Makowski G.S., Ramsby M.L. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection. Clin Chim Acta. 2003;329:77–81. doi: 10.1016/S0009-8981(03)00015-9. - DOI - PubMed

LinkOut - more resources